Skip to main content
SpringerLink
Log in
SpringerLink
Log in

The Radiation Spectrum of Normal Tissue Toxicity and Tolerance — Multiorgan Domino Effect

  • Chapter
Cured II ■ LENT Cancer Survivorship Research and Education

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 534 Accesses

Abstract

Conceptually, normal tissue tolerance is often viewed and defined in terms of a single specific normal tissue/organ site with the clinical illusion that during radiation treatment the adverse effects are localized and limited to those normal tissues within the radiation field. However, with the technological advances of highly computerized treatment delivery and dynamic multileaf collimation, the widespread use of intensity modulated radiation therapy (IMRT) allows for administering higher doses to defined tumor volume contours but in the process delivers more radiation to all the surrounding normal tissues in the axial segments being treated (Fig. 13.1) [1, 2]. Thus, there is an increasing need to recognize the spectrum of normal tissues and organs which are exposed but often obscured in color wash isodose curves. Although each critical structure has radiation tolerance limits well defined, it is important to have a more holistic view of the radiation effects in the large variety of normal tissues adjacent to the tumor, recognizing that all modalities leave the persistence of the memory of an untoward perturbation of their cellular, genetic, and molecular elements (Fig. 13.2) [3].

Percent relative isodose distributions for the 3DCRT plan (a) and IMRT-2 plan (b). The dose distributions show that the IMRT-2 plan is more conformal than the 3DCRT plan at the cost of slightly losing target coverage. Unlike the UTCP plan values, the UTCPQALY values, which incorporate clinically realistic quality of life data, suggest that the UTCPQALY formalism provides better differentiation between plans. (Reprinted with permission from [2])

Animal models for radiation counter-measures research. The overall goal of research is to go from underlying molecular mechanism to human application. This requires many model systems. (Adapted and reprinted with permission from [3]

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Photon Treatment Planning Collaborative Working Group (1991) State-of-the-art of external photon beam radiation treatment planning. Int J Radiat Oncol Biol Phys 21:9–23

    Google Scholar 

  2. Miften M, Gayou O, Parda DS et al (2008) Using quality of life information to rationally incorporate normal tissue effects into treatment plan evaluation and scoring. In: Rubin P, Constine LS, Marks LB, Okunieff P (eds) CURED I — LENT Late effects of cancer treatment on normal tissues. Springer-Verlag, Berlin Heidelberg New York, pp 83–89

    Chapter  Google Scholar 

  3. Stone HB, Moulder JE, Coleman CN et al (2004) Models for evaluating agents intended for prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3–4, 2003. Radiat Res 162:711–728

    Article  CAS  PubMed  Google Scholar 

  4. Hall E (2000) Radiobiology for the radiobiologist, 5th edn. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  5. Elkind MM, Sutton H (1960) Radiation response of mammalian cells grown in culture: 1. Repair of X-ray damage in surviving Chinese hamster cells. Radiat Res 13:556–593

    Article  CAS  PubMed  Google Scholar 

  6. Brown JM (2008) Dedication to Robert Kallman — LENT V scientific meeting. In: Rubin P, Constine LS, Marks LB, Okunieff P (eds) CURED I — LENT Late effects of cancer treatment on normal tissues. Springer-Verlag, Berlin Heidelberg New York, pp V–VI

    Google Scholar 

  7. Rubin P, Casarett G (1968) Clinical radiation pathology, vols. I and II. W.B. Saunders, Philadelphia

    Google Scholar 

  8. Rubin P, Finkelstein J, Shapiro D (1992) Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: interrelationship between the alveolar macrophage and the septal fibroblasts. Int J Radiat Oncol Biol Phys 24:93–101

    CAS  PubMed  Google Scholar 

  9. Rubin P, Scarantino C (1978) The bone marrow organ: the critical structure in radiation-drug interaction. Int J Radiat Oncol Biol Phys 4:3–23

    CAS  PubMed  Google Scholar 

  10. Willey CD, Hallahan DE (2008) Inflammation and cell adhesion molecules are involved in radiation-induced lung injury. In: Rubin P, Constine LS, Marks LB, Okunieff P (eds) CURED I — LENT Late effects of cancer treatment on normal tissues. Springer-Verlag, Berlin Heidelberg New York, pp 23–30

    Chapter  Google Scholar 

  11. Croizat H, Frindel E, Tubiana M (1976) Abscopal effect of irradiation on hematopoetic stem cells of shielded bone marrow. Role of migration. Int J Radiat Biol 30:347–358

    Article  CAS  Google Scholar 

  12. Croizat H, Frindel E, Tubiana M (1970) Proliferative activity of stem cells in the bone marrow of mice after single and multiple irradiations: total-or partial-body exposure. Int J Radiat Biol 18:347–358

    Article  CAS  Google Scholar 

  13. Knospe W, Rayudu V, Cardello M et al (1976) Bone marrow scanning with 52 iron (52Fe). Regeneration and extension of marrow after ablative doses of radiotherapy. Cancer 37:1432–1442

    Article  CAS  PubMed  Google Scholar 

  14. Krause DS, Theise ND, Collector MI et al (2001) Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105:369–377

    Article  CAS  PubMed  Google Scholar 

  15. Greenberger JS (2009) Bioengineering in the repair of irradiated normal tissue by bone marrow derived stem cell populations. In: Rubin P, Constine LS, Marks LB, Okunieff P (eds) CURED II–LENT Late effects of cancer treatment on normal tissues. Springer-Verlag, Berlin Heidelberg New York

    Google Scholar 

  16. Fajardo LF, Stewart JR (1973) Pathogenesis of radiation-induced myocardial fibrosis. Lab Invest 29:244–257

    CAS  PubMed  Google Scholar 

  17. Anscher MS, Vujaskovic Z (2008) Hypoxia-mediated chronic normal tissue injury: a new paradigm and potential strategies for intervention. In: Rubin P, Constine LS, Marks LB, Okunieff P (eds) CURED I — LENT Late effects of cancer treatment on normal tissues. Springer-Verlag, Berlin Heidelberg New York, pp 61–67

    Chapter  Google Scholar 

  18. Fryer CJH, Fitzpatrick PJ, Rider WD et al (1978) Radiation pneumonitis: experience following a large single dose of radiation. Int J Radiat Oncol Biol Phys 4:931–936

    CAS  PubMed  Google Scholar 

  19. Keane TJ, Van Dyk J, Rider WD (1981) Idiopathic interstitial pneumonia following bone marrow transplantation: the relationship with total body irradiation. Int J Radiat Oncol Biol Phys 7:1365–1370

    CAS  PubMed  Google Scholar 

  20. Ingold DK, Reed GB, Kaplan HS et al (1965) Radiation hepatitis. Am J Roentgenol 93:200–208

    CAS  Google Scholar 

  21. Sporn L, Rubin P, Marder V, Wagner D (1984) Irradiation induces release of von Willebrand protein from endothelial cells in culture. Blood 64:567–570

    CAS  PubMed  Google Scholar 

  22. Lyman JT, Wolbarst AB (1987) Optimization of radiation therapy, III: a method of assessing complication probabilities from dose-volume histograms. Int J Radiat Oncol Biol Phys 13:103–109

    CAS  PubMed  Google Scholar 

  23. Kocak Z, Shankar L, Sullivan DC et al (2008) The role of imaging in the study of radiation-induced normal tissue injury. In: Rubin P, Constine LS, Marks LB, Okunieff P (eds) CURED I — LENT Late effects of cancer treatment on normal tissues. Springer-Verlag, Berlin Heidelberg New York, pp 37–45

    Chapter  Google Scholar 

  24. Lawrence TS, Robertson JM, Anscher MD et al (1995) Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31(Special Issue):1237–1248

    CAS  PubMed  Google Scholar 

  25. Adams MJ, Lipshultz SE, Schwartz C (2003) Radiation-associated cardiovascular disease: manifestations and management. Semin Radiat Oncol 13:346–356

    Article  PubMed  Google Scholar 

  26. Adams MJ, Prosnitz RG, Constine LS et al (2008) Screening for cardiovascular disease in survivors of thoracic radiation. In: Rubin P, Constine LS, Marks LB, Okunieff P (eds) CURED I — LENT Late effects of cancer treatment on normal tissues. Springer-Verlag, Berlin Heidelberg New York, pp 47–59

    Chapter  Google Scholar 

  27. Schultheiss TE, Kun LE, Ang KK et al (1995) Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys 31(Special Issue):1093–1112

    CAS  PubMed  Google Scholar 

  28. Gillette EL, Mahler PA, Powers BE et al (1995) Late radiation injury to muscle and peripheral nerves. Int J Radiat Oncol Biol Phys 31(Special Issue):1309–1318

    CAS  PubMed  Google Scholar 

  29. Bonarigo B, Rubin P (1967) Non-union of pathologic fracture after radiation therapy. Radiol 88:889–904

    CAS  Google Scholar 

  30. Hall EJ, Brenner DJ (2008) Second malignancies as a consequence of radiation therapy. In: Rubin P, Constine LS, Marks LB, Okunieff P, eds. CURED I LENT Late Effects of Cancer Treatment on Normal Tissues. Berlin Heidelberg, Germany: Springer-Verlag, pp 77–81

    Chapter  Google Scholar 

  31. Brenner DJ, Curtis RE, Hall EJ (2000) Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 88:398–406

    Article  CAS  PubMed  Google Scholar 

  32. Hall EJ, Wuu CS (2003) Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 33:225–230

    Google Scholar 

  33. Hill RP, Khan MA, Langan AR, Yeung IWT, van Dyke J (2008) Volume effects in radiation damage to rat lung. In: Rubin P, Constine LS, Marks LB, Okunieff P (eds) CURED I — LENT Late effects of cancer treatment on normal tissues. Springer-Verlag, Berlin Heidelberg New York, pp 31–36

    Chapter  Google Scholar 

  34. Rubin P, McDonald S, Maasilta P et al (1989) Serum markers for prediction of pulmonary radiation syndromes. Part I: Surfactant apoprotein. Int J Rad Oncol Biol Phys 17:553–558

    CAS  Google Scholar 

  35. Travis LB, Gospodarowicz M, Curtis RE et al (2002) Lung cancer following chemotherapy for and radiotherapy for Hodgkin’s disease. J Natl Cancer Inst 94:182–192

    PubMed  Google Scholar 

  36. Manis JP (2007) Knock out, knock in, knock down — genetically manipulated mice and the Nobel prize. New Engl J Med 357:2426–2429

    Article  CAS  PubMed  Google Scholar 

  37. Pearlman SH, Rubin P, White HC et al (1990) Fetal hypothalamic transplants into brain irradiated rats: graft morphometry and host behavioral responses. Int J Radiat Oncol Biol Phys 19:293–300

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 647, Rochester, NY, 14642, USA

    Philip Rubin MD (Professor and Chair Emeritus)

Authors
  1. Philip Rubin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 647, Rochester, NY, 14642, USA

    Philip Rubin MD (Professor Emeritus, Chair Emeritus) & Paul Okunieff MD (Philip Rubin Professor of Radiation Oncology, Chair) (Professor Emeritus, Chair Emeritus) &  (Philip Rubin Professor of Radiation Oncology, Chair)

  2. Department of Radiation Oncology James P. Wilmot Cancer Center, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 704, Rochester, NY, 14642, USA

    Louis S. Constine MD (Professor of Radiation Oncology and Pediatrics, Vice Chair) (Professor of Radiation Oncology and Pediatrics, Vice Chair)

  3. Department of Radiation Oncology, University of North Carolina at Chapel Hill, Campus Box 7512, Chapel Hill, NC, 27599, USA

    Lawrence B. Marks MD (Professor and Chair) (Professor and Chair)

  4. Duke University Medical Center, P.O. Box 3085, Durham, NC, 27710, USA

    Lawrence B. Marks MD (Professor and Chair) (Professor and Chair)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Rubin, P. (2008). The Radiation Spectrum of Normal Tissue Toxicity and Tolerance — Multiorgan Domino Effect. In: Rubin, P., Constine, L.S., Marks, L.B., Okunieff, P. (eds) Cured II ■ LENT Cancer Survivorship Research and Education. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-76271-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-76271-3_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-76270-6

  • Online ISBN: 978-3-540-76271-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation